The tweet was deleted by the author.
But we saved everything 🙂.
Crypto billionaires and successful founders are increasingly allocating investments to the biotech and longevity sector after artificial intelligence. Binance founder Yzi Labs has invested approximately 10% of its $10 billion fund in biotech, while Brian Armstrong, co-founder of Coinbase, helped launch the longevity startup Newlimit, now valued at $3.1 billion. Vitalik Buterin has also supported open source bio initiatives. Luke Martin shared these developments.
View post on X Loading...
Luke Martin recently noted that sentiment has shifted from artificial intelligence to crypto, with Bitcoin gaining multiple perceived pathways, in a previous commentary. He has also discussed the potential risks posed by quantum technology for cryptocurrencies, including security concerns for Bitcoin, as outlined in a discussion with Nic Carter. These perspectives have framed ongoing observations around capital allocation across technology sectors.